We recently showed that the DR5 up-regulating agent, neobavaisoflavone, effectively stimulates TRAIL-mediated apoptosis in prostate cancer cells via the intrinsic pathway [67]. This evidence concerns the gene TNFRSF10B and prostate carcinoma.